Floatz logo

FLUOROURACILUM

Stage I Anal Cancer AJCC v8

ECOG-ACRIN Cancer Research GroupSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Stage I Anal Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Carboplatin
ECOG-ACRIN Cancer Research Group
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
M.D. Anderson Cancer Center
Phase 2B
Toripalimab
Sun Yat-sen University
Phase 2B
Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457
M.D. Anderson Cancer Center
Phase 2CCC
Plasmid Encoded Il-12
M.D. Anderson Cancer Center
Phase 2CCC

View all 14 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →